Drugs / OpenBiome FMT Capsule Dose Extended (DE)
OpenBiome FMT Capsule Dose Extended (DE)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04280471 | Sep 2023 → Dec 2024 | acute graft versus host disease | Jonsson Comprehensive Cancer Center | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OpenBiome FMT Capsule Dose Extended (DE) | “Patients ingest OpenBiome FMT Capsule Dose Extended (DE) orally for two consecutive days.” NCT04280471 ↗ |
| Action | Restore | “The purpose of a fecal microbiota transplantation is to use feces from a healthy human donor to replace the abnormal gut bacteria in the recipient.” NCT04280471 ↗ |
| Modality | Other / unclassified | “investigational procedure (fecal microbiota transplantation [FMT])” NCT04280471 ↗ |
| Route | Oral | “Receive OpenBiome FMT Capsule DE PO” NCT04280471 ↗ |